Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development expenses	$ 11,254,538	$ 7,924,450
General and administrative expenses	10,184,773	6,977,936
Total operating expenses	21,439,311	14,902,386
Loss from operations	(21,439,311)	(14,902,386)
Other income:
Interest income	4,346	55,006
Loss before income taxes	(21,434,965)	(14,847,380)
Benefit from income taxes	4,516,488	0
Net loss	(16,918,477)	(14,847,380)
Comprehensive loss	$ (16,918,477)	$ (14,847,380)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.66)	$ (0.89)
Net loss per share, diluted (in dollars per share)	$ (0.66)	$ (0.89)
Weighted average common shares outstanding, basic (in shares)	25,597,125	16,745,044
Weighted average common shares outstanding, diluted (in shares)	25,597,125	16,745,044